Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate

被引：0
|
作者：
Espinet, Blanca [1 ,3 ]
Carla Oliveira, Ana [2 ]
Boque, Concepcion [2 ]
Domingo, Alicia [2 ]
Alonso, Esther [2 ]
Sole, Francesc [1 ,3 ]
机构：
[1] Hosp del Mar, Lab Citogenet & Biol Mol, Serv Patol, IMAS,URNHE PRBB, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Hematol, ICO, Barcelona, Spain
[3] Escola Citol Hematol Soledad Woessner IMAS, Barcelona, Spain
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 04期
关键词：
chronic myeloid leukemia; clonal cytogenetic abnormalities; imatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The emergence of clonal chromosomal abnormalities in Philadelphia-negative cells during treatment with imatinib in patients with Philadelphia-positive chronic myeloid leukemia has been reported. We add information to this issue presenting a series of 29 patients in complete cytogenetic response after imatinib treatment, three of whom developed clonal aberrations.
引用
收藏
页码：556 / 558
页数：4
相关论文
共 50 条
  • [41] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [42] KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
    Marin, D.
    Gabriel, I. H.
    Ahmad, S.
    Foroni, L.
    de Lavallade, H.
    Clark, R.
    O'Brien, S.
    Sergeant, R.
    Hedgley, C.
    Milojkovic, D.
    Khorashad, J. S.
    Bua, M.
    Alsuliman, A.
    Khoder, A.
    Stringaris, K.
    Cooper, N.
    Davis, J.
    Goldman, J. M.
    Apperley, J. F.
    Rezvani, K.
    LEUKEMIA, 2012, 26 (02) : 296 - 302
  • [43] KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
    D Marin
    I H Gabriel
    S Ahmad
    L Foroni
    H de Lavallade
    R Clark
    S O'Brien
    R Sergeant
    C Hedgley
    D Milojkovic
    J S Khorashad
    M Bua
    A Alsuliman
    A Khoder
    K Stringaris
    N Cooper
    J Davis
    J M Goldman
    J F Apperley
    K Rezvani
    Leukemia, 2012, 26 : 296 - 302
  • [44] The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients With Chronic Phase Chronic Myeloid Leukemia After Failure to Front-Line Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    Jabbour, Elias
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Burton, Elizabeth
    Shan, Jenny
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (05) : 421 - 426
  • [45] The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate
    Lee, Sung-Eun
    Choi, Soo Young
    Bang, Ju-Hee
    Kim, Soo-Hyun
    Jang, Eun-jung
    Byeun, Ji-Young
    Park, Jin Eok
    Jeon, Hye-Rim
    Oh, Yun Jeong
    Kim, Myungshin
    Kim, Dong-Wook
    CANCER GENETICS, 2012, 205 (11) : 563 - 571
  • [46] Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation
    Merante, Serena
    Orlandi, Ester
    Bernasconi, Paolo
    Calatroni, Silvia
    Boni, Marina
    Lazzarino, Mario
    HAEMATOLOGICA, 2005, 90 (07) : 979 - 981
  • [47] Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate
    Papaioannou, George
    Athanasiadou, Anastasia
    Voutiadou, Georgia
    Gaitatzi, Maria
    Batsis, Ioannis
    Touloumenidou, Tasoula
    Anagnostopoulos, Achilles
    CANCER GENETICS, 2011, 204 (12) : 692 - 693
  • [48] EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib
    Tao, Zhonfei
    Liu, Bingcheng
    Zhao, Yaozhong
    Wang, Ying
    Zhang, Rongli
    Han, Mingzhe
    Zhang, Li
    Li, Chengwen
    Ru, Kun
    Mi, Yingchang
    Wang, Jianxiang
    LEUKEMIA RESEARCH, 2014, 38 (09) : 1030 - 1035
  • [49] Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia
    Oliveira, G. A. P.
    Costa, E. S.
    Freitas, M. S.
    Dutra, F. F.
    Maia, S. F.
    Guerra, M. C.
    Tabernero, M. D.
    Borojevic, R.
    Otazu, I. B.
    Silva, J. L.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (06) : 580 - 584
  • [50] Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia
    Guevara, Gonzalo
    Gonzalez, Jaime A.
    Lopera, Diego E.
    Gonzalez, Manuel
    Saavedra, Jose D.
    Lobaton, Jose Fernando
    Duque, Jorge Enrique
    COLOMBIA MEDICA, 2012, 43 (04): : 267 - 272
12345